RUTHERFORD, N.J., Sept. 20, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (CGIX) ("CGIX" or the "Company"), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers, was featured in an article in USA TODAY titled "Targeted therapy and companion diagnostics go hand and hand." The article is available online at:

http://us.mediaplanet.com/future-of-cancer-care/hand-in-hand-how-targeted-therapy-and-companion-diagnostics-are-changing-outcomes-for-cancer-patients

Additionally, the September 20 print edition of USA TODAY features a panel discussion with Dr. Raju Chaganti, founder and chairman of CGIX. In the panel discussion, Dr. Chaganti and other leading oncology experts share insights about advancements that are impacting the future of cancer care.

The panel discussion includes information on the newest diagnostic and treatment options available to patients, how changes in technology have impacted cancer care, forecasts for new technology advancements, and other topics driving innovation in the industry.

"The Future of Cancer Care" insert will be available in print editions of USA TODAY on September 20 in the following markets: New York City, Philadelphia, Washington D.C., Baltimore, Cincinnati and Chicago. USA TODAY online sites have 26.3 million unique visitors per month. An online version of the insert is available at:

http://us.mediaplanet.com/future-of-cancer-care/

A PDF of the insert as featured in USA TODAY is available at:

http://doc.mediaplanet.com/all_projects/12832.pdf

CGIX is a sponsor of "The Future of Cancer Care" insert.

About Cancer Genetics:

View original post here:
Cancer Genetics, Inc. Featured in USA TODAY Article

Comments are closed.